Study of IV tenoxicam for analgesia after major orthopedic surgery
New Egyptian Journal of Medicine [The]. 1994; 10 (6): 2936-40
in English
| IMEMR
| ID: emr-34495
ABSTRACT
A controlled double blind study after major orthopedic surgery was done to compare a single I. V. dose of tenoxicam [20 mg] with placebo in 78 patients. It was associated with a reduction in consumption of morphine as assessed by patient-controlled analgesia. The consumption of morphine in tenoxicam group when compared with placebo was significantly reduced by 57% during the first 12 hour [P <0.002] and nonsignificantly reduced by 19.9% during the next 12-24 hour after operation [P >0.05]. When tenoxicam used as a single I.V. dose [20 mg], it has no significant effect on blood loss, bleeding tendency, or platelet functions. The possible adverse effects on hematological and renal functions are not recorded in their results:
Search on Google
Index:
IMEMR (Eastern Mediterranean)
Main subject:
Orthopedics
/
Analgesia
Language:
English
Journal:
New Egypt. J. Med.
Year:
1994
Similar
MEDLINE
...
LILACS
LIS